Fisher Asset Management
BSX icon

Fisher Asset Management’s Boston Scientific BSX Stock Holding History

Fisher Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.2M Sell
333,528
-117,075
-26% -$6.36M ﹤0.01% 383
2026
Q1 		$28.3M Sell
450,603
-8,687,613
-95% -$695M 0.01% 290
2025
Q4 		$871M Buy
9,138,216
+677,191
+8% +$66.4M 0.3% 84
2025
Q3 		$826M Buy
8,461,025
+755,641
+10% +$78.3M 0.3% 89
2025
Q2 		$828M Buy
7,705,384
+939,834
+14% +$95.1M 0.33% 84
2025
Q1 		$683M Buy
6,765,550
+964,638
+17% +$97.1M 0.3% 87
2024
Q4 		$518M Buy
5,800,912
+1,028,977
+22% +$90.6M 0.21% 90
2024
Q3 		$400M Buy
4,771,935
+694,585
+17% +$54.8M 0.16% 101
2024
Q2 		$314M Buy
4,077,350
+66,996
+2% +$4.9M 0.14% 106
2024
Q1 		$275M Buy
4,010,354
+24,555
+0.6% +$1.58M 0.13% 115
2023
Q4 		$230M Buy
3,985,799
+15,357
+0.4% +$820K 0.12% 123
2023
Q3 		$210M Buy
3,970,442
+131,207
+3% +$6.88M 0.12% 137
2023
Q2 		$208M Buy
3,839,235
+51,352
+1% +$2.68M 0.11% 147
2023
Q1 		$190M Buy
3,787,883
+36,948
+1% +$1.74M 0.12% 151
2022
Q4 		$174M Buy
3,750,935
+50,033
+1% +$2.17M 0.12% 145
2022
Q3 		$143M Buy
3,700,902
+95,591
+3% +$3.83M 0.11% 148
2022
Q2 		$134M Buy
3,605,311
+100,331
+3% +$4.08M 0.1% 137
2022
Q1 		$155M Buy
3,504,980
+130,838
+4% +$5.67M 0.09% 135
2021
Q4 		$143M Buy
3,374,142
+94,661
+3% +$3.98M 0.08% 152
2021
Q3 		$142M Buy
3,279,481
+131,038
+4% +$5.8M 0.09% 137
2021
Q2 		$135M Buy
3,148,443
+118,503
+4% +$4.99M 0.08% 138
2021
Q1 		$117M Buy
3,029,940
+114,430
+4% +$4.33M 0.08% 147
2020
Q4 		$105M Buy
2,915,510
+119,530
+4% +$4.31M 0.08% 155
2020
Q3 		$107M Buy
2,795,980
+84,556
+3% +$3.26M 0.09% 140
2020
Q2 		$95.2M Buy
2,711,424
+589,237
+28% +$21.2M 0.09% 140
2020
Q1 		$69.2M Buy
2,122,187
+2,104,416
+11,842% +$82.2M 0.09% 145
2019
Q4 		$804K Buy
17,771
+438
+3% +$18.3K ﹤0.01% 611
2019
Q3 		$705K Buy
17,333
+2,289
+15% +$97K ﹤0.01% 644
2019
Q2 		$647K Buy
15,044
+4,957
+49% +$191K ﹤0.01% 640
2019
Q1 		$387K Sell
10,087
-276
-3% -$10.5K ﹤0.01% 671
2018
Q4 		$366K Buy
+10,363
New +$376K ﹤0.01% 690

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Fisher Asset Management's BSX Position: Q2 2026 in Review

Fisher Asset Management reduced its Boston Scientific (BSX) stake by 26% in Q2 2026, selling an estimated $6.36M and leaving 333,528 shares worth $14.2M. The position accounts for ﹤0.01% of the portfolio, ranked #383.

Fisher Asset Management first reported a position in BSX in Q4 2018 and has held it in 31 quarters since. The position peaked at $871M in Q4 2025. 770 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Fisher Asset Management held 333,528 shares of Boston Scientific worth $14.2M as of Q2 2026.
  • Fisher Asset Management sold 117,075 Boston Scientific shares in Q2 2026, an estimated $6.36M.
  • Boston Scientific made up ﹤0.01% of Fisher Asset Management's portfolio in Q2 2026, its #383 holding.
  • Fisher Asset Management first reported a position in Boston Scientific in Q4 2018 and has held it in 31 quarters since.
  • Fisher Asset Management's Boston Scientific position peaked at $871M in Q4 2025.
  • 770 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.